Stay updated on 2-Dose IV Mg vs 1-Dose+Budesonide in Severe Asthma Clinical Trial
Sign up to get notified when there's something new on the 2-Dose IV Mg vs 1-Dose+Budesonide in Severe Asthma Clinical Trial page.

Latest updates to the 2-Dose IV Mg vs 1-Dose+Budesonide in Severe Asthma Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedCore study content remains unchanged (arms, outcomes, eligibility criteria, and status). The observed differences are minor UI tweaks and a slightly different update timestamp, which do not affect the study information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check19 days agoNo Change Detected
- Check41 days agoChange DetectedMajor update: page now includes a funding-related operational notice and announces version 3.2.0, replacing the previous 3.1.0.SummaryDifference4%

- Check48 days agoChange DetectedThe page updates the version to v3.1.0 and adds two new contact numbers (+974-55336166 and +974-55312922), replacing the previous revision marker v3.0.2.SummaryDifference0.1%

- Check62 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2; Back to Top link/button removed.SummaryDifference0.3%

- Check69 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.3%

- Check77 days agoChange DetectedThe web page has undergone significant changes, including the addition of a facility name and location, while extensive drug-related information has been removed, indicating a shift in focus or content strategy.SummaryDifference5%

Stay in the know with updates to 2-Dose IV Mg vs 1-Dose+Budesonide in Severe Asthma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the 2-Dose IV Mg vs 1-Dose+Budesonide in Severe Asthma Clinical Trial page.